Skip to main content
Update Location

My Location

Update your location to show providers, locations, and services closest to you.

Enter a zip code
Or
Select a campus/region

Biljana Horn, MD

Pediatric Hematologist/Oncologist (Child Cancer Specialist)

Photo of Biljana Horn

Research at a glance

Top areas of exploration

  • Hematopoietic Stem Cell Transplantation , 31 publications
  • Graft vs Host Disease , 12 publications
  • Transplantation Conditioning , 11 publications
  • Transplantation, Homologous , 10 publications

Research activity

56 publications

1,358 citations

Why is this important?

Active clinical trials

BMT12108, Non-Myeloablative Conditioning and Bone Marrow Transplantation

Allogeneic blood or marrow transplantation (alloBMT) is a curative therapy for a variety of hematologic disorders, including sickle cell disease and thalassemia. Even when it is clear that alloBMT can give to these patients an improvement in their…

Investigators
Jordan Milner, Biljana Horn
Status
Accepting Candidates
Ages
1 Year - 70 Years
Sexes
All
Conditioning SCID Infants Diagnosed Early (CSIDE)

The investigators want to study if lower doses of chemotherapy will help babies with SCID to achieve good immunity with less short and long-term risks of complications after transplantation. This trial identifies babies with types of immune…

Investigators
Jordan Milner, Biljana Horn
Status
Accepting Candidates
Ages
0 Years - 2 Years
Sexes
All

My publications

56 publications

2024

An International Learning Collaborative Phase 2 Trial for Haploidentical Bone Marrow Transplant in Sickle Cell Disease.

Blood

PubMed Publisher's site

2023

Feasibility study of busulfan, fludarabine, and thiotepa conditioning regimen for allogeneic hematopoietic stemcell transplantationfor children and young adults with nonmalignant disorders

Pediatric Blood & Cancer

Publisher's site

2023

Polygenic Pharmacogenomic Markers as Predictors of Toxicity Phenotypes in the Treatment of Acute Lymphoblastic Leukemia: A Single-Center Study

JCO Precision Oncology

Publisher's site

2022

Impact of Adequate Day 30 Post-Pediatric Hematopoietic Stem Cell Transplantation Vitamin D Level on Clinical Outcome: An Observational Cohort Study.

Transplantation and cellular therapy

PubMed Publisher's site

2022

Outcomes in Hematopoietic Stem Cell Transplantation for Congenital Amegakaryocytic Thrombocytopenia

Transplantation and Cellular Therapy

PubMed Publisher's site